Hemostemix’s Expands its Marketing Team Focused on Sales in Florida
Calgary, Alberta–(Newsfile Corp. – August 14, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), an autologous stem cell company developing and commercializing VesCell™ (ACP-01), announces the appointment of…